Background Type 1 diabetes is a chronic autoimmune disease that leads to destruction of
insulin-producing beta cells and dependence on exogenous insulin for survival. Some …

Background Dapagliflozin is a sodium-glucose cotransporter-2 inhibitor approved for the
treatment of type 2 diabetes. We aimed to assess the efficacy and safety of dapagliflozin as an …

SARS-CoV-2 in Children and Risk of Type 1 Diabetes Despite biologic plausibility,
systematic testing for SARS-CoV-2 and type 1 diabetes in children in this prospective …

Most screening programs to identify individuals at risk for type 1 diabetes have targeted
relatives of people living with the disease to improve yield and feasibility. However, ∼90% of …

Importance Public health screening for type 1 diabetes in its presymptomatic stages may
reduce disease severity and burden on a population level. Objective To determine the …

Background Antibody responses to virus reflect exposure and potential protection. Methods
We developed a highly specific and sensitive approach to measuring antibodies against …

Aims/hypothesis More than 40 regions of the human genome confer susceptibility for type 1
diabetes and could be used to establish population screening strategies. The aim of our …

FIGURE 1 The stages of type 1 diabetes (T1D)(DiabetesTrialNet. org). A proportion of individuals
who have increased genetic risk of T1D progress at variable rates to immune activation …

OBJECTIVE Previous studies showed that inhibiting lymphocyte costimulation reduces
declining β-cell function in individuals newly diagnosed with type 1 diabetes. We tested whether …

Immune tolerance is executed partly by Foxp3 + regulatory T (Treg) cells, which suppress
autoreactive T cells. In autoimmune type 1 diabetes (T1D) impaired tolerance promotes …